ANI Pharmaceuticals, Inc. (ANIP) compared with its closest peers (ARWR, IONS, MDGL, COLL, CORT): P/E 15.3 vs industry 17.2. Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Arrowhead Pharmaceuticals, Ionis Pharmaceuticals, Madrigal Pharmaceuticals, Collegium Pharmaceutical, Corcept Therapeutics, Emergent BioSolutions, ACADIA Pharmaceuticals, Amphastar Pharmaceuticals, Supernus Pharmaceuticals and Prestige Consumer Healthcare share ANI Pharmaceuticals's sub-industry, pharmaceutical makers.
| Company | Market Cap | P/E |
|---|---|---|
| Arrowhead Pharmaceuticals, Inc. (ARWR) | $12.31B | -3453.0 |
| Ionis Pharmaceuticals, Inc. (IONS) | $9.93B | -33.2 |
| Madrigal Pharmaceuticals, Inc. (MDGL) | $11.94B | -45.4 |
| Collegium Pharmaceutical, Inc. (COLL) | $882.75M | 19.4 |
| Corcept Therapeutics Incorporated (CORT) | $13.22B | 42.5 |
| Emergent BioSolutions Inc. (EBS) | $262.37M | 2.3 |
| ACADIA Pharmaceuticals Inc. (ACAD) | $5.05B | 13.4 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | $952.41M | 15.7 |
| Supernus Pharmaceuticals, Inc. (SUPN) | $2.66B | -73.0 |
| Prestige Consumer Healthcare Inc. (PBH) | $2.43B | 14.1 |
| Stock P/E | 15.3 |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
| vs Sector | -29.8% |
| vs Industry | -11.2% |
ANIP overview · ANIP earnings · ANIP financials · ANIP KPIs · ANIP documents · ANIP ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.